Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Plus Therapeutics, Inc. (PSTV) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$1.39M |
|
$5.15M |
|
-- |
|
$1.39M |
|
$2.93M |
|
$-1.54M |
|
$6.69M |
|
$5.15M |
|
$5.15M |
|
$5.15M |
|
$5.15M |
|
$5.15M |
|
$5.15M |
|
$-1.54M |
|
$-1.46M |
|
48.39M |
|
209.16M |
|
$0.02 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$9.21M |
|
$0.29M |
|
$1.14M |
|
$10.35M |
|
$7.32M |
|
-- |
|
-- |
|
$7.32M |
|
$3.03M |
|
$2.26M |
|
$3.03M |
|
92.18M |
|
| Cash Flow Statement Financials | |
$-11.97M |
|
$-1.07M |
|
$15.20M |
|
$0.08M |
|
$2.23M |
|
$2.16M |
|
$0.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.26 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
100.00% |
|
-110.65% |
|
-110.65% |
|
-- |
|
370.58% |
|
370.58% |
|
$-11.95M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
-- |
|
1.36 |
|
66.11 |
|
169.78% |
|
227.82% |
|
49.77% |
|
169.78% |
|
$0.03 |
|
$-0.06 |
|
$-0.06 |
|